{"version":"facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-01T21:08:02.462704+00:00","family":{"fact_type":"exchange_compliance_notice","slug":"exchange-compliance","label":"Listing & Compliance Notices","sec_items":["3.01"]},"filters":{"ticker":null,"since":null},"pagination":{"limit":50,"returned":50,"next_cursor":"2026-05-22T12:15:26+00:00|9346"},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"exchange_compliance_notice","fact_key":"ac181f7844e2742f4d26ab1eb8a6ae9bc84ede5a","cik":1558569,"ticker":"ISPC","company_name":"iSpecimen Inc.","filed_at":"2026-06-01T21:00:15+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-29","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"iSpecimen Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 29, 2026, iSpecimen Inc. (the “Company”)\nreceived a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1) (the “Rule”), which requires a minimum\nof $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market (the “Capital Market”). As reported in the Company’s Quarterly Report\non Form 10-Q for the period ended March 31, 2026, the Company had stockholders’ equity of $814,038. Nasdaq noted that, as of May\n29, 2026, the Company doe","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-063575","anchor_url":"https://secwatch.observer/filing/0001213900-26-063575#claim-ac181f7844e2742f4d26ab1eb8a6ae9bc84ede5a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1558569/000121390026063575/0001213900-26-063575-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"269315b34b94663010e7cf3c30925229a980022d","cik":64472,"ticker":"GENC","company_name":"GENCOR INDUSTRIES INC","filed_at":"2026-06-01T20:09:26+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2026-11-18","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nyse_american","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-19","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["1007"],"rules_cited_in_text":true},"claim":"GENCOR INDUSTRIES INC received a nyse_american deficiency notice notice regarding late filing (rules 1007).","evidence_excerpt":"May 19, 2026, Gencor Industries, Inc. (the “Company”) received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company was not in compliance with the NYSE American LLC (“NYSE American”) continued listing standards as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”) prior to May 18, 2026, the end of the extension period provided by Form 12b-25, and as a result was subject to the procedures set forth in Section 1007 of the NY","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-251421","anchor_url":"https://secwatch.observer/filing/0001193125-26-251421#claim-269315b34b94663010e7cf3c30925229a980022d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/64472/000119312526251421/0001193125-26-251421-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"16d3f72f94d0a04f7e37e912ee25c212be9b26fb","cik":1897245,"ticker":"HWH","company_name":"HWH International Inc.","filed_at":"2026-05-29T21:21:49+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"$2.5 million","notice_date":"2026-05-29","notice_type":"deficiency_notice","plan_due_date":"2026-07-13","raw_rule_text":"Listing Rule 5550(b)(1)","reported_value":"$2,078,220","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"HWH International Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 29, 2026 HWH International Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications\nDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’\nequity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1) because the Company’s stockholders’\nequity of $2,078,220 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2026 was below the\nrequired minimum of $2.5 million, and because, as of May 29, 2026, the Company did","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-026442","anchor_url":"https://secwatch.observer/filing/0001493152-26-026442#claim-16d3f72f94d0a04f7e37e912ee25c212be9b26fb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1897245/000149315226026442/0001493152-26-026442-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"8025b29d0e73741c3ec7d9898fa2e5256dcf5dcc","cik":1388320,"ticker":"ATNM","company_name":"Actinium Pharmaceuticals, Inc.","filed_at":"2026-05-29T21:10:41+00:00","payload":{"company_response":"intends to submit a plan","compliance_status":"plan_due","cure_deadline":"2027-11-27","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nyse_american","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$4.0 million","notice_date":"2026-05-27","notice_type":"deficiency_notice","plan_due_date":"2026-06-26","raw_rule_text":"Section 1003(a)(ii) of the NYSE American Company Guide","reported_value":"$2.3 million","rule_numbers":["1003(a)(ii)","1003(a)(iii)"],"rules_cited_in_text":true},"claim":"Actinium Pharmaceuticals, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).","evidence_excerpt":"May 27, 2026, Actinium Pharmaceuticals, Inc.\n(the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating\nthat the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company\nGuide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more\nif it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31,\n2026, the Company reported stockholders’ equity of approximately","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-062935","anchor_url":"https://secwatch.observer/filing/0001213900-26-062935#claim-8025b29d0e73741c3ec7d9898fa2e5256dcf5dcc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390026062935/0001213900-26-062935-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"d82d83d9c115522efe82b3b0bab9dad96082dafa","cik":1709628,"ticker":"CSAI","company_name":"CLOUDASTRUCTURE, INC.","filed_at":"2026-05-29T21:09:11+00:00","payload":{"company_response":"intends to file Form 10-Q before compliance plan due date; if unable, will submit plan by July 25, 2026","compliance_status":"plan_due","cure_deadline":"2026-11-16","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"timely filing of all required periodic financial reports","notice_date":"2026-05-26","notice_type":"deficiency_notice","plan_due_date":"2026-07-25","raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":"Form 10-Q for period ended March 31, 2026 not yet filed","rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"CLOUDASTRUCTURE, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 26, 2026, Cloudastructure,\nInc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq\nStock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for\nthe period ended March 31, 2026 (“Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which\nrequires timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company requires additional\ntime to review and confirm the accounting treatment for its outstand","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001683168-26-004399","anchor_url":"https://secwatch.observer/filing/0001683168-26-004399#claim-d82d83d9c115522efe82b3b0bab9dad96082dafa","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1709628/000168316826004399/0001683168-26-004399-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"fd058537e627777ed3e6b37f16853d00a1037072","cik":1809750,"ticker":"EDBL","company_name":"Edible Garden AG Inc","filed_at":"2026-05-29T21:00:24+00:00","payload":{"company_response":"intends to timely request a hearing","compliance_status":"delisting_pending","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":"2026-06-05","exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-27","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(a)(2) ... minimum bid price of at least $1 per share","reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)(iv)"],"rules_cited_in_text":true},"claim":"Edible Garden AG Inc received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).","evidence_excerpt":"May 27, 2026, Edible Garden AG Incorporated (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for at least 30 consecutive business days, the Company no longer meets Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1 per share (the “Bid Price Rule”). Under Nasdaq Listing Rule 5810(c)(3)(A)(iv), because the Company has effected a reverse stock split over the prior one-year per","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-003501","anchor_url":"https://secwatch.observer/filing/0001477932-26-003501#claim-fd058537e627777ed3e6b37f16853d00a1037072","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1809750/000147793226003501/0001477932-26-003501-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"511c83ffafe9937f5fc825f00458a420964c435c","cik":1329606,"ticker":"CETY","company_name":"Clean Energy Technologies, Inc.","filed_at":"2026-05-29T20:57:27+00:00","payload":{"company_response":"working diligently to complete and file the Quarterly Report","compliance_status":"deficient","cure_deadline":"2026-07-27","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"file all required periodic reports with the SEC","notice_date":"2026-05-26","notice_type":"deficiency_notice","plan_due_date":"2026-07-27","raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Clean Energy Technologies, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 26, 2026, Clean Energy Technologies, Inc. (the “ Company ”) received a written notice (the “ Notice ”)\nfrom the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not\nin compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because the Company had not yet filed its Quarterly\nReport on Form 10-Q for the period ended March 31, 2026 (the “ Quarterly Report ”). The\nRule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has\nno immediate effect on the listing","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-026412","anchor_url":"https://secwatch.observer/filing/0001493152-26-026412#claim-511c83ffafe9937f5fc825f00458a420964c435c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1329606/000149315226026412/0001493152-26-026412-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"b42590e3f6a82626e222d51ce7c7f353a4a6761e","cik":885462,"ticker":"GURE","company_name":"GULF RESOURCES, INC.","filed_at":"2026-05-29T20:45:30+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2026-10-12","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-26","notice_type":"deficiency_notice","plan_due_date":"2026-06-22","raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"GULF RESOURCES, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 26, 2026, Gulf Resources\n(the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq\nStock Market LLC (“Nasdaq”), indicating that, as a result of not having timely filed its quarterly report on Form 10-Q for\nthe quarter ended March 31, 2026 (the “Form 10-Q”), and the Company remains delinquent in filing its annual report on Form\n10-K for the year ended December 31, 2025 (the “Initial Delinquent Filing”), the Company is in non-compliance with Nasdaq\nListing Rule 5250(c)(1), which requires timely filing all required periodic financial reports wit","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193805-26-000723","anchor_url":"https://secwatch.observer/filing/0001193805-26-000723#claim-b42590e3f6a82626e222d51ce7c7f353a4a6761e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/885462/000119380526000723/0001193805-26-000723-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"9009ec1d1bc07782e194edbf73e1c157762b8e9b","cik":1825452,"ticker":"ONFO","company_name":"Onfolio Holdings, Inc","filed_at":"2026-05-29T20:30:53+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2026-07-10","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2,500,000","notice_date":"2026-05-26","notice_type":"deficiency_notice","plan_due_date":"2026-07-10","raw_rule_text":"Nasdaq Listing Rule 5550(b)(1)","reported_value":"$1,216,603","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Onfolio Holdings, Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 26, 2026, Onfolio Holdings Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) informing the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice states that the Company’s Quarterly Report on Form 10-Q for the for the period ended March 31, 2026 reported stockholders’ equity of $1,216,603. As of the date of the Notice","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001654954-26-005548","anchor_url":"https://secwatch.observer/filing/0001654954-26-005548#claim-9009ec1d1bc07782e194edbf73e1c157762b8e9b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426005548/0001654954-26-005548-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"7089ce1fb4219e8074df6e5d9b30e40d11566821","cik":1726711,"ticker":"ADTX","company_name":"Aditxt, Inc.","filed_at":"2026-05-29T20:21:24+00:00","payload":{"company_response":null,"compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":"2026-06-11","immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-27","notice_type":"hearing_update","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(a)(2) and 5550(b)(1)","reported_value":null,"rule_numbers":["5550(a)(2)","5550(b)(1)"],"rules_cited_in_text":true},"claim":"Aditxt, Inc. received a nasdaq hearing update notice regarding other (rules 5550(a)(2), 5550(b)(1)).","evidence_excerpt":"May 27, 2026, Aditxt, Inc. (the “Company”)\nreceived a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market\nLLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s\nQuarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum\nstockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)\n(the “Stockholders’ Equity Requirement”). The Letter further","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-062844","anchor_url":"https://secwatch.observer/filing/0001213900-26-062844#claim-7089ce1fb4219e8074df6e5d9b30e40d11566821","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"a8cb4f58d81f4522c0ac331ffff07a74bf78e7fd","cik":1726711,"ticker":"ADTX","company_name":"Aditxt, Inc.","filed_at":"2026-05-29T20:21:24+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2,500,000","notice_date":"2026-05-27","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(b)(1)","reported_value":"$(35,174,386)","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Aditxt, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 27, 2026, Aditxt, Inc. (the “Company”)\nreceived a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market\nLLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s\nQuarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum\nstockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)\n(the “Stockholders’ Equity Requirement”). The Letter further","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-062844","anchor_url":"https://secwatch.observer/filing/0001213900-26-062844#claim-a8cb4f58d81f4522c0ac331ffff07a74bf78e7fd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"a07356300dc58a4378860c156c28bede3bdd1f28","cik":1753162,"ticker":"FTHM","company_name":"Fathom Holdings Inc.","filed_at":"2026-05-29T20:15:13+00:00","payload":{"company_response":"The Company intends to file the Form 10-Q as promptly as possible to regain compliance; if unable to file by July 21, 2026, it intends to submit a plan of compliance.","compliance_status":"deficient","cure_deadline":"2026-07-21","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-05-22","notice_type":"deficiency_notice","plan_due_date":"2026-07-21","raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Fathom Holdings Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 22, 2026, Fathom Holdings Inc. (the “Company”) received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “Filing Requirement”). In accordance with Nasdaq’s listing rules, the Company has 60 calendar days from the date of the notification letter","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0001628280-26-039190","anchor_url":"https://secwatch.observer/filing/0001628280-26-039190#claim-a07356300dc58a4378860c156c28bede3bdd1f28","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1753162/000162828026039190/0001628280-26-039190-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"c7b8c3207f700a6f5e5f211fde150b92180640e6","cik":1963685,"ticker":"RR","company_name":"RICHTECH ROBOTICS INC.","filed_at":"2026-05-28T20:49:32+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-05-22","notice_type":"deficiency_notice","plan_due_date":"2026-07-21","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"RICHTECH ROBOTICS INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 22, 2026, Richtech\n Robotics Inc., a Nevada corporation (the “ Company ”) received a notice (the “ Notice ”) from the Listing\n Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company is not in compliance\n with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), because it has not timely filed its Quarterly Report on Form 10-Q\n for the period ended March 31, 2026 (the “ Form 10-Q ”) with the U.S. Securities and Exchange Commission (the “ SEC ”). The\n Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Com","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-062172","anchor_url":"https://secwatch.observer/filing/0001213900-26-062172#claim-c7b8c3207f700a6f5e5f211fde150b92180640e6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1963685/000121390026062172/0001213900-26-062172-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"ef92be692bc256c00032956b96f23806ba75089a","cik":1896212,"ticker":"CDT","company_name":"CDT Equity Inc.","filed_at":"2026-05-28T20:30:30+00:00","payload":{"company_response":"The Company anticipates filing its Form 10-Q as soon as the review process of the current draft is complete, thereby regaining compliance with the Periodic Filing Requirement.","compliance_status":"deficient","cure_deadline":"2026-07-20","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"CDT Equity Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, CDT Equity Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Listing\nQualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with\nNasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Requirement”) because the Company did not file its Quarterly Report\non Form 10-Q for the three-month period ended March 31, 2026 (the “Form 10-Q”) in a timely manner, as required for continued\nlisting on The Nasdaq Capital Market. The Notice has no immediate effect on the listing or trading of the Company’s","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-025629","anchor_url":"https://secwatch.observer/filing/0001493152-26-025629#claim-ef92be692bc256c00032956b96f23806ba75089a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315226025629/0001493152-26-025629-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"0da9e66fc784e822ba0e0cc5aad2623153900d2e","cik":1780201,"ticker":"LVLU","company_name":"Lulu's Fashion Lounge Holdings, Inc.","filed_at":"2026-05-28T20:01:22+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(b)(1)","reported_value":null,"rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Lulu's Fashion Lounge Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 21, 2026, Lulu’s Fashion Lounge Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is out of compliance with the minimum of $2.5 million of stockholders’ equity required for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(1). The Company’s stockholders’ equity as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 29, 2026 was approximately $(525) thousand. The Company does not meet the a","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-067467","anchor_url":"https://secwatch.observer/filing/0001104659-26-067467#claim-0da9e66fc784e822ba0e0cc5aad2623153900d2e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1780201/000110465926067467/0001104659-26-067467-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"cb8de74797c709985dc9f69d81238e8a677f017d","cik":1589149,"ticker":"GWAV","company_name":"Greenwave Technology Solutions, Inc.","filed_at":"2026-05-27T21:25:20+00:00","payload":{"company_response":"working to complete and file the Late Filings","compliance_status":"plan_due","cure_deadline":"2026-10-12","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"delisting_notice","plan_due_date":"2026-06-22","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Greenwave Technology Solutions, Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, the Company received an additional delinquency notification letter (the “Notice”) from Nasdaq due to the Company’s\nfailure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended March","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-025454","anchor_url":"https://secwatch.observer/filing/0001493152-26-025454#claim-cb8de74797c709985dc9f69d81238e8a677f017d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1589149/000149315226025454/0001493152-26-025454-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"c82acdec964b29c636cf58309c902970a1b95a16","cik":1997296,"ticker":"MDCX","company_name":"Medicus Pharma Ltd.","filed_at":"2026-05-27T20:45:00+00:00","payload":{"company_response":"The Company intends to actively monitor its MVLS and will consider available strategies to regain compliance with Nasdaq","compliance_status":"deficient","cure_deadline":"2026-11-16","deficiency_type":"market_value","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"Market value of listed securities of at least $35,000,000","notice_date":"2026-05-20","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"Nasdaq Listing Rule 5550(b)(2), 5550(b)(1), 5550(b)(3), 5810(c)(3)(C)","reported_value":"MVLS below $35,000,000 for 30 consecutive business days","rule_numbers":["5550(b)(2)","5550(b)(1)","5550(b)(3)","5810(c)(3)(C)"],"rules_cited_in_text":true},"claim":"Medicus Pharma Ltd. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3), 5810(c)(3)(C)).","evidence_excerpt":"May 20, 2026, the Company received written notice (the \"Notice\") from the Listing Qualifications Department of the Nasdaq notifying the Company that it is not in compliance with the minimum Market Value of Listed Securit","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001062993-26-002900","anchor_url":"https://secwatch.observer/filing/0001062993-26-002900#claim-c82acdec964b29c636cf58309c902970a1b95a16","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1997296/000106299326002900/0001062993-26-002900-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"0c2c660a3239e64c463867a55ed0c7ba483b5272","cik":2024459,"ticker":"CHAR","company_name":"Charlton Aria Acquisition Corp","filed_at":"2026-05-27T20:41:44+00:00","payload":{"company_response":"intends to file as promptly as possible; if unable by June 15, 2026, intends to submit a compliance plan","compliance_status":"deficient","cure_deadline":"2026-06-15","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"timely filing of Form 10-Q","notice_date":"2026-05-22","notice_type":"noncompliance_notice","plan_due_date":"2026-06-15","raw_rule_text":"Nasdaq Listing Rule 5250(c)(1)","reported_value":"Form 10-Q not filed","rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Charlton Aria Acquisition Corp received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 22, 2026, Charlton\nAria Acquisition Corporation (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications\nDepartment of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-061545","anchor_url":"https://secwatch.observer/filing/0001213900-26-061545#claim-0c2c660a3239e64c463867a55ed0c7ba483b5272","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2024459/000121390026061545/0001213900-26-061545-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"53a6353803e5f7b4241632d59cdd853f2db72f6a","cik":1178697,"ticker":"SONM","company_name":"DNA X, Inc.","filed_at":"2026-05-27T20:35:28+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"2500000","notice_date":"2026-05-22","notice_type":"noncompliance_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":"-983000","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"DNA X, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests\na hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025433","anchor_url":"https://secwatch.observer/filing/0001493152-26-025433#claim-53a6353803e5f7b4241632d59cdd853f2db72f6a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"685ca6783ee7bd2ae6cbff72020573d224377166","cik":1178697,"ticker":"SONM","company_name":"DNA X, Inc.","filed_at":"2026-05-27T20:35:28+00:00","payload":{"company_response":"hearing_requested","compliance_status":"delisting_pending","cure_deadline":"2026-05-29","deficiency_type":"stockholders_equity","delisting_effective_date":"2026-06-02","exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-22","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"DNA X, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 22, 2026, the Company received a delisting determination letter from the Staff advising the Company that unless the Company requests\na hearing before a Nasdaq Hearing Panel (the “Panel”) to appeal Nasdaq’s delisting","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025433","anchor_url":"https://secwatch.observer/filing/0001493152-26-025433#claim-685ca6783ee7bd2ae6cbff72020573d224377166","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226025433/0001493152-26-025433-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"4bed6402d8e2d89d0da71ced1007f60871bb510b","cik":1971387,"ticker":"LIMN","company_name":"Liminatus Pharma, Inc.","filed_at":"2026-05-27T20:30:41+00:00","payload":{"company_response":"appeal_requested","compliance_status":"hearing_requested","cure_deadline":"2026-05-18","deficiency_type":"market_value","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":"2026-05-26","immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-20","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5450(b)(2)(A)","5450(b)(2)(C)"],"rules_cited_in_text":true},"claim":"Liminatus Pharma, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(2)(C)).","evidence_excerpt":"May 20, 2026, the Company received a notice\nfrom Nasdaq stating that the Company had not regained compliance with the MVLS Rule and the MVPHS Rule. Accordingly, its securities will\nbe delisted from The Nasdaq Global Mark","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-066974","anchor_url":"https://secwatch.observer/filing/0001104659-26-066974#claim-4bed6402d8e2d89d0da71ced1007f60871bb510b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"7f087591254e0cc1fc1f7de26be955d8aa38d2a4","cik":1852973,"ticker":"BRLS","company_name":"Borealis Foods Inc.","filed_at":"2026-05-27T20:15:20+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2026-10-12","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":"2026-06-16","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Borealis Foods Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, a notice\n(the “ Notice ”) from The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, because the\nCompany has not yet filed the Q12026 Form 10-Q, the Company no longer complies with Nasdaq Lis","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-061511","anchor_url":"https://secwatch.observer/filing/0001213900-26-061511#claim-7f087591254e0cc1fc1f7de26be955d8aa38d2a4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1852973/000121390026061511/0001213900-26-061511-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"46bcb83562bce51564c4f2ce272b1a946175ba81","cik":1269026,"ticker":"SINT","company_name":"Sintx Technologies, Inc.","filed_at":"2026-05-27T19:00:23+00:00","payload":{"company_response":"The Company intends to timely submit a compliance plan to Nasdaq.","compliance_status":"plan_due","cure_deadline":"2026-07-06","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"2500000","notice_date":"2026-05-22","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":"904000","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Sintx Technologies, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 22, 2026, SINTX Technologies, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications\nDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in complia","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001493152-26-025377","anchor_url":"https://secwatch.observer/filing/0001493152-26-025377#claim-46bcb83562bce51564c4f2ce272b1a946175ba81","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1269026/000149315226025377/0001493152-26-025377-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"257d74a0e89a94bf450c8af31d322dc9d75881c5","cik":1425627,"ticker":"SOBR","company_name":"SOBR Safe, Inc.","filed_at":"2026-05-27T13:15:35+00:00","payload":{"company_response":"requested continued listing and presented plan to regain compliance","compliance_status":"extension_granted","cure_deadline":"2026-09-15","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":"2026-04-28","immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"hearing_update","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"SOBR Safe, Inc. received a nasdaq hearing update notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"May 21, 2026, the Company received a letter from the Hearings Panel granting the Company’s request for continued listing until September 15, 2026, in order to allow the Company to regain compliance with the Bid Price Req","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-26-003444","anchor_url":"https://secwatch.observer/filing/0001477932-26-003444#claim-257d74a0e89a94bf450c8af31d322dc9d75881c5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1425627/000147793226003444/0001477932-26-003444-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"9613264941c69e2eb8972e7517d298d8e1ec33c6","cik":1850059,"ticker":"FSHP","company_name":"Flag Ship Acquisition Corp","filed_at":"2026-05-27T13:10:43+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Flag Ship Acquisition Corp received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, Flag Ship Acquisition Corporation\n(the “Company”) received an additional deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications\nDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) as a res","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001829126-26-005698","anchor_url":"https://secwatch.observer/filing/0001829126-26-005698#claim-9613264941c69e2eb8972e7517d298d8e1ec33c6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1850059/000182912626005698/0001829126-26-005698-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"c3c9defc075742f0ff247d9128ae85e0d208d06d","cik":1890361,"ticker":"ASPC","company_name":"ASPAC III Acquisition Corp.","filed_at":"2026-05-27T12:30:16+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-20","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"ASPAC III Acquisition Corp. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"he “Minimum Stockholders’ Equity Requirement”)\nrequired for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1), the Company no longer complies with Nasdaq’s continued\nlisting rules on The Nasdaq Capital Market.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-061249","anchor_url":"https://secwatch.observer/filing/0001213900-26-061249#claim-c3c9defc075742f0ff247d9128ae85e0d208d06d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1890361/000121390026061249/0001213900-26-061249-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"b0bc157322326a3e4e59bccae8b03da17043ffa6","cik":1866226,"ticker":"EMAT","company_name":"Evolution Metals & Technologies Corp.","filed_at":"2026-05-26T21:28:49+00:00","payload":{"company_response":"Filed Form 10-Q on May 22, 2026; received compliance reinstatement notice on May 26, 2026","compliance_status":"regained_compliance","cure_deadline":"2026-05-22","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"timely file periodic financial reports","notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":"Form 10-Q for period ended March 31, 2026 not filed by due date","rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Evolution Metals & Technologies Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, Evolution Metals & Technologies\nCorp. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The\nNasdaq Stock Market LLC (“Nasdaq”) notifying the Company that","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-061113","anchor_url":"https://secwatch.observer/filing/0001213900-26-061113#claim-b0bc157322326a3e4e59bccae8b03da17043ffa6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1866226/000121390026061113/0001213900-26-061113-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"ab2cf4d07859b38d48cfa05c197175fcd5475d65","cik":1898604,"ticker":"VSTD","company_name":"Vestand Inc.","filed_at":"2026-05-26T21:18:59+00:00","payload":{"company_response":null,"compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-19","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Vestand Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 19, 2026, the Company received a Staff Delisting Determination letter (the “Staff Determination”) from Nasdaq notifying\nit that Nasdaq has initiated a process which could result in the delisting of the Company’s secu","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025277","anchor_url":"https://secwatch.observer/filing/0001493152-26-025277#claim-ab2cf4d07859b38d48cfa05c197175fcd5475d65","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1898604/000149315226025277/0001493152-26-025277-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"46b6dab1686cd1fdb21227ae78439b924744e1bf","cik":1832511,"ticker":"PIII","company_name":"P3 Health Partners Inc.","filed_at":"2026-05-26T20:06:05+00:00","payload":{"company_response":null,"compliance_status":"regained_compliance","cure_deadline":null,"deficiency_type":"market_value","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-20","notice_type":"compliance_regained","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(2)"],"rules_cited_in_text":true},"claim":"P3 Health Partners Inc. received a nasdaq compliance regained notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"May 20, 2026, the Company received a letter from the Staff notifying the Company that, based on the Company’s Form 8-K filed with the SEC on May 15, 2026, the Staff has determined that the Company complies with Nasdaq Li","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001832511-26-000026","anchor_url":"https://secwatch.observer/filing/0001832511-26-000026#claim-46b6dab1686cd1fdb21227ae78439b924744e1bf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000026/0001832511-26-000026-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"261f757f19e212a1dba46358b89805692bea83ae","cik":2030954,"ticker":"XHLD","company_name":"TEN Holdings, Inc.","filed_at":"2026-05-26T20:05:22+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-26","notice_type":"deficiency_notice","plan_due_date":"2026-07-10","raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"TEN Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 26, 2026, the Company received a deficiency letter from the Listing Qualifications Department (the “ Staff ”)\nof The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasda","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-025244","anchor_url":"https://secwatch.observer/filing/0001493152-26-025244#claim-261f757f19e212a1dba46358b89805692bea83ae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2030954/000149315226025244/0001493152-26-025244-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"9b5e458bfae820990709ae6faee30760e883e70e","cik":2028201,"ticker":"COLA","company_name":"Columbus Acquisition Corp/Cayman Islands","filed_at":"2026-05-26T20:00:26+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2026-11-18","deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$50 million MVLS","notice_date":"2026-05-22","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":"market value of listed securities below the $50 million minimum","reported_value":null,"rule_numbers":["5450(b)(2)(A)"],"rules_cited_in_text":true},"claim":"Columbus Acquisition Corp/Cayman Islands received a nasdaq deficiency notice notice regarding other (rules 5450(b)(2)(A)).","evidence_excerpt":"May 22, 2026, Columbus\nAcquisition Corp, a Cayman Islands exempted company (the “ Company ”) received written notice (the “ Minimum\nHolders Notice ”) from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-061006","anchor_url":"https://secwatch.observer/filing/0001213900-26-061006#claim-9b5e458bfae820990709ae6faee30760e883e70e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2028201/000121390026061006/0001213900-26-061006-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"c56ade78e28f894703bba2b3db91172e1ab17fa6","cik":2028201,"ticker":"COLA","company_name":"Columbus Acquisition Corp/Cayman Islands","filed_at":"2026-05-26T20:00:26+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"400 holders","notice_date":"2026-05-22","notice_type":"deficiency_notice","plan_due_date":"2026-07-06","raw_rule_text":"minimum of 400 holders for continued listing on Nasdaq","reported_value":null,"rule_numbers":["5450(a)(2)"],"rules_cited_in_text":true},"claim":"Columbus Acquisition Corp/Cayman Islands received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).","evidence_excerpt":"May 22, 2026, Columbus\nAcquisition Corp, a Cayman Islands exempted company (the “ Company ”) received written notice (the “ Minimum\nHolders Notice ”) from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001213900-26-061006","anchor_url":"https://secwatch.observer/filing/0001213900-26-061006#claim-c56ade78e28f894703bba2b3db91172e1ab17fa6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2028201/000121390026061006/0001213900-26-061006-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"38c3bf3eefde615ba2c4a9a28c491779e135ddbb","cik":1829635,"ticker":"RNAZ","company_name":"Transcode Therapeutics, Inc.","filed_at":"2026-05-26T10:43:50+00:00","payload":{"company_response":"expected to submit Compliance Plan including conversion of Series A Preferred Stock","compliance_status":"plan_due","cure_deadline":"2026-07-03","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"2500000","notice_date":"2026-05-19","notice_type":"deficiency_notice","plan_due_date":"2026-07-03","raw_rule_text":null,"reported_value":"1251427","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Transcode Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 19, 2026, TransCode Therapeutics,\nInc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of\nthe Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001104659-26-065959","anchor_url":"https://secwatch.observer/filing/0001104659-26-065959#claim-38c3bf3eefde615ba2c4a9a28c491779e135ddbb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465926065959/0001104659-26-065959-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"be3536144b1b4f962359ed3bb334edc4c55a95e5","cik":1836875,"ticker":"NVVE","company_name":"Nuvve Holding Corp.","filed_at":"2026-05-22T22:35:13+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-22","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Nuvve Holding Corp. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 22, 2026, Nuvve Holding Corp. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, since the Company","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001836875-26-000036","anchor_url":"https://secwatch.observer/filing/0001836875-26-000036#claim-be3536144b1b4f962359ed3bb334edc4c55a95e5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1836875/000183687526000036/0001836875-26-000036-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"20dfa7fcc9b9e134e0380cc7917716f0691c6e68","cik":1911545,"ticker":"GITS","company_name":"Global Interactive Technologies, Inc.","filed_at":"2026-05-22T21:29:03+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2026-10-12","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":"2026-06-22","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Global Interactive Technologies, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, Global Interactive Technologies, Inc. (the “ Company ”)\nreceived a delinquency compliance alert notice (the “ Notice ”) from the Staff of the Listing Qualifications Department\n(the “ Staff ”) of The Nasdaq","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-025090","anchor_url":"https://secwatch.observer/filing/0001493152-26-025090#claim-20dfa7fcc9b9e134e0380cc7917716f0691c6e68","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1911545/000149315226025090/0001493152-26-025090-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"9b80a33cda5d7954fa530eff935c3a1e456bec4a","cik":1544227,"ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-05-22T21:28:16+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":null,"deficiency_type":"board_independence","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-22","notice_type":"noncompliance_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":[],"rules_cited_in_text":false},"claim":"Tempest Therapeutics, Inc. received a nasdaq noncompliance notice notice regarding board independence.","evidence_excerpt":"May 22, 2026, Tempest Therapeutics, Inc. (the “Company”) notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the majority independent director requirement under Nasdaq Listing","confidence":0.8,"filing_url":"https://secwatch.observer/filing/0001193125-26-237207","anchor_url":"https://secwatch.observer/filing/0001193125-26-237207#claim-9b80a33cda5d7954fa530eff935c3a1e456bec4a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/0001193125-26-237207-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"f73f9a17ab8a4f3f20cdd08462e9c61b5b43e174","cik":1544227,"ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","filed_at":"2026-05-22T21:28:16+00:00","payload":{"company_response":"Company intends to submit a compliance plan on or before July 6, 2026.","compliance_status":"plan_due","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"2500000","notice_date":"2026-05-19","notice_type":"deficiency_notice","plan_due_date":"2026-07-06","raw_rule_text":null,"reported_value":"822000","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Tempest Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 19, 2026, Tempest Therapeutics, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-26-237207","anchor_url":"https://secwatch.observer/filing/0001193125-26-237207#claim-f73f9a17ab8a4f3f20cdd08462e9c61b5b43e174","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237207/0001193125-26-237207-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"7f433de9151c0ee6ef1a29b196359be8f0854f2a","cik":1807887,"ticker":"LASE","company_name":"Laser Photonics Corp","filed_at":"2026-05-22T21:27:31+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2026-11-16","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"Form 10-Q for period ended March 31, 2026","notice_date":"2026-03-31","notice_type":"deficiency_notice","plan_due_date":"2026-07-20","raw_rule_text":null,"reported_value":null,"rule_numbers":[],"rules_cited_in_text":false},"claim":"Laser Photonics Corp received a nasdaq deficiency notice notice regarding late filing.","evidence_excerpt":"received a notice from Nasdaq Listing Qualifications\ndepartment of the Nasdaq Stock Market LLC (“Nasdaq”) stating that since it had not received the Company’s Form 10-Q\nfor the period ended March 31, 2026, the Company does not comply with Nasdaq’s Listing Rules for continued listing. Nasdaq stated\nthat the Company has 60 days to submit a plan to regain compliance with respect to this delinquent report. Nasdaq can grant an exception\nto allow the Company to regain compliance up to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or\nNovember 16, 2026. A\ncopy of t","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-025087","anchor_url":"https://secwatch.observer/filing/0001493152-26-025087#claim-7f433de9151c0ee6ef1a29b196359be8f0854f2a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1807887/000149315226025087/0001493152-26-025087-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"04db49d733b0ddd26b75804f42a7da9a0d722587","cik":1879403,"ticker":"LRHC","company_name":"La Rosa Holdings Corp.","filed_at":"2026-05-22T21:20:15+00:00","payload":{"company_response":"Company intends to file late reports or submit a plan by June 15, 2026","compliance_status":"plan_due","cure_deadline":"2026-10-12","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":"2026-06-15","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)","5810(b)"],"rules_cited_in_text":true},"claim":"La Rosa Holdings Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1), 5810(b)).","evidence_excerpt":"May 21, 2026, the Company received a notice\n(the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company is\ndelinquent in filing its Form 10-Q and remains delinquent in filin","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-060667","anchor_url":"https://secwatch.observer/filing/0001213900-26-060667#claim-04db49d733b0ddd26b75804f42a7da9a0d722587","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1879403/000121390026060667/0001213900-26-060667-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"d8ddeb14d9d41b17322c6216759d00988b9d8f12","cik":1673481,"ticker":"SEGG","company_name":"Sports Entertainment Gaming Global Corp","filed_at":"2026-05-22T21:15:40+00:00","payload":{"company_response":"The Company intends to submit a plan to regain compliance within the required timeframe and is working diligently to complete and file the Form 10-Q as soon as practicable.","compliance_status":"deficient","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"noncompliance_notice","plan_due_date":"2026-07-20","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Sports Entertainment Gaming Global Corp received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, SEGG Media Corporation (the “Company”) received a written notice (the “Notice”) from the Listing\nQualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in com","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-025075","anchor_url":"https://secwatch.observer/filing/0001493152-26-025075#claim-d8ddeb14d9d41b17322c6216759d00988b9d8f12","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1673481/000149315226025075/0001493152-26-025075-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"94f0145267853653ac4dcf5599309b6457d6cf6d","cik":1560293,"ticker":"TNON","company_name":"Tenon Medical, Inc.","filed_at":"2026-05-22T21:15:15+00:00","payload":{"company_response":"evaluating courses of action and intends to timely submit a compliance plan","compliance_status":"deficient","cure_deadline":null,"deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":"$2,500,000","notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":"2026-07-06","raw_rule_text":null,"reported_value":"$1,895,000","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 21, 2026, Tenon Medical, Inc. (the “Company”)\nreceived a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated May 21, 2026, notifying\nthe Company that it is no longer in compliance with the","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-060662","anchor_url":"https://secwatch.observer/filing/0001213900-26-060662#claim-94f0145267853653ac4dcf5599309b6457d6cf6d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026060662/0001213900-26-060662-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"f3372247cdfd9dee0d68b040a0beac1088d213ad","cik":8177,"ticker":"AAME","company_name":"ATLANTIC AMERICAN CORP","filed_at":"2026-05-22T21:01:50+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":null,"deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"ATLANTIC AMERICAN CORP received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 21, 2026, Atlantic American Corporation (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock\n Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001140361-26-022626","anchor_url":"https://secwatch.observer/filing/0001140361-26-022626#claim-f3372247cdfd9dee0d68b040a0beac1088d213ad","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/8177/000114036126022626/0001140361-26-022626-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"a975c3945af153e7ee1e9e810e341ac30cb8dfd7","cik":1716947,"ticker":"ENSC","company_name":"Ensysce Biosciences, Inc.","filed_at":"2026-05-22T20:55:24+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2026-07-06","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-21","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Ensysce Biosciences, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 21, 2026, Ensysce Biosciences Inc. (the “ Company ”) received notice from the Listing Qualifications Department\nof The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that due to the Company’s non-compliance with the $2","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-26-025061","anchor_url":"https://secwatch.observer/filing/0001493152-26-025061#claim-a975c3945af153e7ee1e9e810e341ac30cb8dfd7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226025061/0001493152-26-025061-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"fdc0a0773d1d689ba3ab590cf0b2099524a6fea9","cik":2067627,"ticker":"NKLR","company_name":"Terra Innovatum Global N.V.","filed_at":"2026-05-22T20:32:34+00:00","payload":{"company_response":"intends to regain compliance as soon as practicable","compliance_status":"deficient","cure_deadline":"2026-06-15","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-05-19","notice_type":"deficiency_notice","plan_due_date":"2026-06-15","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"Terra Innovatum Global N.V. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 19, 2026, Terra Innovatum Global N.V. (the “Company”)\nreceived an expected deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock\nMarket LLC (“Nasdaq”) notifying the Co","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001213900-26-060614","anchor_url":"https://secwatch.observer/filing/0001213900-26-060614#claim-fdc0a0773d1d689ba3ab590cf0b2099524a6fea9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/2067627/000121390026060614/0001213900-26-060614-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"dd78215bb91d1a4ab6427ff22338ec60952a86d6","cik":935419,"ticker":"RICK","company_name":"RCI HOSPITALITY HOLDINGS, INC.","filed_at":"2026-05-22T20:23:08+00:00","payload":{"company_response":null,"compliance_status":"deficient","cure_deadline":"2026-07-20","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":null,"notice_date":"2026-05-20","notice_type":"deficiency_notice","plan_due_date":"2026-07-20","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"RCI HOSPITALITY HOLDINGS, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 20, 2026, RCI Hospitality Holdings, Inc. (“we,” “us” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that we are","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-26-037742","anchor_url":"https://secwatch.observer/filing/0001628280-26-037742#claim-dd78215bb91d1a4ab6427ff22338ec60952a86d6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/935419/000162828026037742/0001628280-26-037742-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"9687284dc7e3a19aeab306227984f7b56ae2488a","cik":1829635,"ticker":"RNAZ","company_name":"Transcode Therapeutics, Inc.","filed_at":"2026-05-22T20:15:37+00:00","payload":{"company_response":"plan_to_submit","compliance_status":"plan_due","cure_deadline":"2026-07-03","deficiency_type":"stockholders_equity","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"2500000","notice_date":"2026-05-19","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":"1251427","rule_numbers":["5550(b)(1)"],"rules_cited_in_text":true},"claim":"Transcode Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 19, 2026, TransCode Therapeutics, Inc. (the “Company”)\nreceived a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”)\nnotifying the Company that it is not","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001104659-26-065728","anchor_url":"https://secwatch.observer/filing/0001104659-26-065728#claim-9687284dc7e3a19aeab306227984f7b56ae2488a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1829635/000110465926065728/0001104659-26-065728-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"7cb2e12cf8f418d5cfe31ff9d0600578f95228ff","cik":1854480,"ticker":"DEVS","company_name":"DevvStream Corp.","filed_at":"2026-05-22T20:05:36+00:00","payload":{"company_response":"intends to submit views in writing","compliance_status":"delisting_pending","cure_deadline":"2026-05-18","deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-20","notice_type":"deficiency_notice","plan_due_date":"2026-05-27","raw_rule_text":null,"reported_value":null,"rule_numbers":[],"rules_cited_in_text":false},"claim":"DevvStream Corp. received a nasdaq deficiency notice notice regarding other.","evidence_excerpt":"May 20, 2026, due to the expiration of the Net Income Compliance Extension, the Company received formal notification\n that it has not regained compliance with the Net Income Requirement and that, accordingly, the Panel w","confidence":0.85,"filing_url":"https://secwatch.observer/filing/0001140361-26-022598","anchor_url":"https://secwatch.observer/filing/0001140361-26-022598#claim-7cb2e12cf8f418d5cfe31ff9d0600578f95228ff","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1854480/000114036126022598/0001140361-26-022598-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"1e7f9566813666ed068c8a3ab2ba228265f2bfb0","cik":1854480,"ticker":"DEVS","company_name":"DevvStream Corp.","filed_at":"2026-05-22T20:05:36+00:00","payload":{"company_response":"requested hearing","compliance_status":"hearing_requested","cure_deadline":null,"deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":"2025-05-19","immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-04-07","notice_type":"noncompliance_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5450(a)(1)","5810(c)(3)(A)(iv)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"DevvStream Corp. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)(iv), 5810(c)(3)(A)).","evidence_excerpt":"April 7, 2026, the Company received a separate written notification (the “ Bid Price\n Notice ”) from Nasdaq indicating that because the bid price for the Company’s common shares, no par value (“ Common Shares ”), for the","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001140361-26-022598","anchor_url":"https://secwatch.observer/filing/0001140361-26-022598#claim-1e7f9566813666ed068c8a3ab2ba228265f2bfb0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1854480/000114036126022598/0001140361-26-022598-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"7294fb212ce439818f1f1320fb6dd314d7f9caed","cik":1840877,"ticker":"COCH","company_name":"Envoy Medical, Inc.","filed_at":"2026-05-22T20:05:31+00:00","payload":{"company_response":null,"compliance_status":"extension_granted","cure_deadline":"2026-11-16","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":false,"minimum_requirement":"$1.00 per share for 30 consecutive business days","notice_date":"2026-05-19","notice_type":"deficiency_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)","5810(c)(3)(A)"],"rules_cited_in_text":true},"claim":"Envoy Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"May 19, 2026, the Company received a second staff notification\nfrom Nasdaq informing the Company that, although the Company had not met the Bid Price Requirement by the Compliance Date, the Company\nis eligible for an add","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001213900-26-060556","anchor_url":"https://secwatch.observer/filing/0001213900-26-060556#claim-7294fb212ce439818f1f1320fb6dd314d7f9caed","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"1aebd7e6b2d05352e769c36ba7be445d14a7342e","cik":1314052,"ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-05-22T12:15:26+00:00","payload":{"company_response":null,"compliance_status":"plan_due","cure_deadline":"2026-07-20","deficiency_type":"late_filing","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2026-05-20","notice_type":"deficiency_notice","plan_due_date":"2026-07-20","raw_rule_text":null,"reported_value":null,"rule_numbers":["5250(c)(1)"],"rules_cited_in_text":true},"claim":"ANAVEX LIFE SCIENCES CORP. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"May 20, 2026, Anavex Life Sciences Corp. (the “Company”)\nreceived a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market\nLLC (“Nasdaq”) indicating that, as","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001731122-26-000781","anchor_url":"https://secwatch.observer/filing/0001731122-26-000781#claim-1aebd7e6b2d05352e769c36ba7be445d14a7342e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm"}]}